세계의 나노입자 위탁생산 시장 보고서(2025년)
Nanoparticles Contract Manufacturing Global Market Report 2025
상품코드 : 1825830
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

나노입자 위탁생산 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 CAGR 12.1%로 57억 9,000만 달러로 성장할 것입니다. 예측 기간의 성장은 약물전달 시스템에 대한 지식 증가, 나노기술 및 재료과학의 발전, 첨단 약물전달 시스템에 대한 수요, 암 치료에서 금속 나노입자에 대한 높은 수요, 제약회사의 급격한 성장에 기인하는 것으로 추정됩니다. 예측 기간의 주요 동향으로는 업계 리더들 간의 전략적 제휴, 기술 발전, 지속가능하고 친환경적인 나노입자 제조 방법으로의 전환, 식음료 포장에 나노입자의 통합, 기술 통합 등이 있습니다.

향후 5년간 12.1%의 성장률 전망은 지난번 예측보다 0.9% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 독일과 스위스에서 조달하는 지질 나노입자 제조 시스템 및 특수 바이오리액터의 비용을 상승시키고, mRNA 치료제 개발을 지연시키거나 바이오 제조 비용을 상승시킴으로써 미국 제약 산업을 저해할 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

연구 활동에 대한 자원 배분 증가는 나노입자 위탁생산 시장의 확대를 촉진할 태세를 갖추고 있습니다. 연구 투자에는 과학적 지식 향상, 혁신적 기술 개발, 특정 과제 해결을 위한 연구 수행을 위한 재정적 지원이 포함됩니다. 연구 투자 증가에는 기술 혁신에 대한 집중, 사회적 문제에 대한 인식 증가, 신흥 기술에 대한 지원, 지원 정책, 정부의 자금 지원 이니셔티브 등 여러 가지 요인이 기여하고 있습니다. 이러한 투자는 기술 혁신을 촉진하고, 맞춤형을 가능하게 하고, 품질 관리를 보장하고, 확장성을 촉진하고, 학제 간 협력을 촉진하고, 시장 범위를 확장하고, 경제 개발을 촉진함으로써 나노입자의 위탁 제조를 촉진하는 데 도움이되었습니다. 예를 들어, 영국 정부는 2023년 4월 공공 연구개발(R&D) 지출을 대폭 늘려 2024-2025 회계연도까지 220억 파운드(276억 4,000만 달러)의 예산을 책정하고, R&D를 강화하여 국내 혁신을 촉진하겠다는 의지를 밝혔습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Nanoparticle contract manufacturing involves outsourcing the production of nanoparticles to third-party manufacturers or contract manufacturing organizations (CMOs). These services offer a versatile solution for various industries, providing customized nanoparticle formulations and expertise to meet specific application requirements and drive innovation across diverse fields.

The primary types of the nanoparticle contract manufacturing market include metal nanoparticles, lipid nanoparticles, and other nanoparticles. Metal nanoparticles are minute particles of metal typically ranging from 1 to 100 nanometers in size. These nanoparticles are manufactured at various scales, including commercial, clinical, and pre-clinical, for applications such as therapeutics, diagnostics, and vaccines. They are utilized by various end-users, including pharmaceutical and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The nanoparticles contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides nanoparticles contract manufacturing market statistics, including nanoparticles contract manufacturing industry global market size, regional shares, competitors with a nanoparticles contract manufacturing market share, detailed nanoparticles contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the nanoparticles contract manufacturing industry. This nanoparticles contract manufacturing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nanoparticles contract manufacturing market size has grown rapidly in recent years. It will grow from $3.27 billion in 2024 to $3.67 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to a rising preference for contract manufacturing, increasing need for nanomaterials across various applications, increased usage of therapeutics drug delivery applications, rising demand for nanomedicine, and demand for high-quality nanoparticles.

The nanoparticles contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $5.79 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing knowledge about pharmaceutical delivery systems, advancement in nanotechnology and materials science, demand for advanced drug delivery systems, high demand for metal nanoparticles in cancer therapy, and rapid growth of pharmaceutical companies. Major trends in the forecast period include strategic partnership among industry leaders, technological advancement, the shift towards sustainable and eco-friendly nanoparticle production methods, integration of nanoparticles in food and beverage packaging, and integration of technology.

The forecast of 12.1% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. pharmaceutical industry by increasing the cost of lipid nanoparticle production systems and specialized bioreactors sourced from Germany and Switzerland, thereby delaying mRNA therapeutic development and elevating biomanufacturing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing allocation of resources towards research activities is poised to drive the expansion of the nanoparticle contract manufacturing market. Research investments encompass financial support directed at conducting studies to advance scientific knowledge, develop innovative technologies, and address specific challenges. Several factors contribute to the rise in research investments, including a focus on innovation, heightened awareness of societal issues, backing for emerging technologies, supportive policies, and government funding initiatives. These investments are instrumental in advancing nanoparticle contract manufacturing by fostering technological innovation, enabling customization, ensuring quality control, facilitating scalability, encouraging interdisciplinary collaboration, expanding market reach, and fostering economic development. For example, the UK government announced a substantial increase in public Research and Development (R&D) expenditures in April 2023, with plans to elevate the budget to £22 billion ($27.64 billion) by fiscal year 2024-2025, demonstrating a commitment to enhancing R&D efforts and promoting innovation domestically.

Key players in the nanoparticle contract manufacturing market are leveraging innovative technologies, such as commercial formulation systems, to produce medicines for clinical and commercial purposes and maintain a competitive advantage. Commercial formulation systems provide comprehensive platforms for efficient development and production of nanoparticle-based products. For instance, Cytiva, a US-based provider of life sciences products and solutions, introduced the NanoAssemblr commercial formulation system in July 2023. This system minimizes the risk of cross-contamination, particularly crucial for genomic medicines, by employing a single-use fluid path. It enhances production efficiency by reducing downtime for sanitization and cleaning, enabling the manufacture of multiple lipid nanoparticle products within the same facility. The system features 21 CFR Part 11-compliant software for electronic batch records, real-time monitoring of flow rate, and automated processes such as priming, calibration, formulation, and in-line dilution.

In February 2022, Merck KGaA, a Germany-based technology company, acquired Exelead Inc. for $780 million. This acquisition allows Merck to strengthen its mRNA capabilities and solidify its position as a leading contract development and manufacturing organization in the mRNA vaccine and therapeutic sector. Exelead Inc., a US-based biopharmaceutical company, specializes in lipid nanoparticles (LNP) and complex injectable formulations, with a focus on mRNA therapeutics.

Major companies operating in the nanoparticles contract manufacturing market are AstraZeneca plc, Evonik Industries AG, Emergent BioSolutions Inc., CordenPharma International GmbH, Ajinomoto Bio-Pharma Services, IBA Worldwide, BioVectra Inc., Mevion Medical Systems Inc., Fortis Life Sciences, Ascendia Pharmaceuticals LLC, LSNE Contract Manufacturing, Precision NanoSystems Inc., Ardena Holding NV, American Elements, Polymun Scientific Immunbiologische Forschung GmbH, Danfysik A/S, Hitachi Chemical Advanced Therapeutics Solutions LLC, Axolabs GmbH, AVANSA Technology & Services, Cytodiagnostics Inc., Encapsula NanoSciences LLC, MyBiotech GmbH, Nanochemazone, RiboPro GmbH, TechNano India

North America was the largest region in the nanoparticles contract manufacturing market in 2024. The regions covered in the nanoparticles contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nanoparticles contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nanoparticle contract manufacturing market includes revenues earned by entities by providing services such as custom synthesis, scale-up production, and surface modification and functionalization and related drug delivery nanoparticles, diagnostic nanoparticles, cosmetic nanoparticles, and electronic nanoparticles. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nanoparticles Contract Manufacturing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nanoparticles contract manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for nanoparticles contract manufacturing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanoparticles contract manufacturing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Nanoparticles Contract Manufacturing Market Characteristics

3. Nanoparticles Contract Manufacturing Market Trends And Strategies

4. Nanoparticles Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Nanoparticles Contract Manufacturing Growth Analysis And Strategic Analysis Framework

6. Nanoparticles Contract Manufacturing Market Segmentation

7. Nanoparticles Contract Manufacturing Market Regional And Country Analysis

8. Asia-Pacific Nanoparticles Contract Manufacturing Market

9. China Nanoparticles Contract Manufacturing Market

10. India Nanoparticles Contract Manufacturing Market

11. Japan Nanoparticles Contract Manufacturing Market

12. Australia Nanoparticles Contract Manufacturing Market

13. Indonesia Nanoparticles Contract Manufacturing Market

14. South Korea Nanoparticles Contract Manufacturing Market

15. Western Europe Nanoparticles Contract Manufacturing Market

16. UK Nanoparticles Contract Manufacturing Market

17. Germany Nanoparticles Contract Manufacturing Market

18. France Nanoparticles Contract Manufacturing Market

19. Italy Nanoparticles Contract Manufacturing Market

20. Spain Nanoparticles Contract Manufacturing Market

21. Eastern Europe Nanoparticles Contract Manufacturing Market

22. Russia Nanoparticles Contract Manufacturing Market

23. North America Nanoparticles Contract Manufacturing Market

24. USA Nanoparticles Contract Manufacturing Market

25. Canada Nanoparticles Contract Manufacturing Market

26. South America Nanoparticles Contract Manufacturing Market

27. Brazil Nanoparticles Contract Manufacturing Market

28. Middle East Nanoparticles Contract Manufacturing Market

29. Africa Nanoparticles Contract Manufacturing Market

30. Nanoparticles Contract Manufacturing Market Competitive Landscape And Company Profiles

31. Nanoparticles Contract Manufacturing Market Other Major And Innovative Companies

32. Global Nanoparticles Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nanoparticles Contract Manufacturing Market

34. Recent Developments In The Nanoparticles Contract Manufacturing Market

35. Nanoparticles Contract Manufacturing Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기